Project sponsor

CND Life Sciences

Since our founding, CND Life Sciences has been on a mission to advance the care of patients who face the potential diagnosis of a neurodegenerative disease. With long careers in research and clinical care, our founders  set out to unlock  deeper stories within the skin by  detecting key pathological markers in the peripheral nervous system that had been previously out of reach.

Website

Fall 2025

Automated Coverslipping Design to Prevent Image Disturbances in Tissue Scans Used for Neurological Disorder Diagnosis

Our concept works to prevent image disturbances in pathology scans by making an automated design for coverslipping. The design will work to create reproducible quality slides through increased consistency via robotic activity. CND Life Sciences aids in the diagnosis of Parkinson’s through skin biopsy in order to successfully provide a diagnosis before clinical onset. Current…

Automated Skin Punch Biopsy Tool

The Syn-One skin biopsy test, developed by CND Life Sciences, is a novel diagnostic tool that provides pathological evidence of Parkinson’s disease, dementia with Lewy bodies, and related synucleinopathies. However, during a 20-month period, CND Life Sciences reported a high rate of unusable skin punch biopsy samples due to variability in technique, creating the need…